ツムラの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/03/29 | 3,630 | 3,635 | 3,570 | 3,580 | -20 | -0.6% | 248,500 |
2017/03/28 | 3,570 | 3,615 | 3,550 | 3,600 | +95 | +2.7% | 284,600 |
2017/03/27 | 3,485 | 3,530 | 3,475 | 3,505 | +10 | +0.3% | 212,500 |
2017/03/24 | 3,480 | 3,525 | 3,475 | 3,495 | +10 | +0.3% | 191,400 |
2017/03/23 | 3,475 | 3,505 | 3,455 | 3,485 | +25 | +0.7% | 260,400 |
2017/03/22 | 3,415 | 3,480 | 3,410 | 3,460 | -25 | -0.7% | 267,200 |
2017/03/21 | 3,490 | 3,510 | 3,465 | 3,485 | +5 | +0.1% | 205,000 |
2017/03/17 | 3,490 | 3,495 | 3,435 | 3,480 | -45 | -1.3% | 223,200 |
2017/03/16 | 3,475 | 3,535 | 3,470 | 3,525 | +30 | +0.9% | 282,200 |
2017/03/15 | 3,450 | 3,510 | 3,445 | 3,495 | +35 | +1% | 251,600 |
2017/03/14 | 3,470 | 3,500 | 3,445 | 3,460 | +5 | +0.1% | 187,700 |
2017/03/13 | 3,435 | 3,465 | 3,430 | 3,455 | +25 | +0.7% | 190,000 |
2017/03/10 | 3,425 | 3,450 | 3,420 | 3,430 | +55 | +1.6% | 202,800 |
2017/03/09 | 3,400 | 3,400 | 3,360 | 3,375 | -5 | -0.1% | 132,600 |
2017/03/08 | 3,395 | 3,395 | 3,360 | 3,380 | -15 | -0.4% | 196,400 |
2017/03/07 | 3,405 | 3,410 | 3,385 | 3,395 | -20 | -0.6% | 194,800 |
2017/03/06 | 3,415 | 3,430 | 3,390 | 3,415 | ±0 | ±0% | 240,800 |
2017/03/03 | 3,430 | 3,455 | 3,395 | 3,415 | -20 | -0.6% | 182,000 |
2017/03/02 | 3,415 | 3,440 | 3,400 | 3,435 | +60 | +1.8% | 259,100 |
2017/03/01 | 3,360 | 3,395 | 3,350 | 3,375 | +45 | +1.4% | 277,200 |
2017/02/28 | 3,350 | 3,375 | 3,325 | 3,330 | +15 | +0.5% | 375,700 |
2017/02/27 | 3,350 | 3,350 | 3,280 | 3,315 | -80 | -2.4% | 509,100 |
2017/02/24 | 3,440 | 3,450 | 3,380 | 3,395 | -60 | -1.7% | 271,600 |
2017/02/23 | 3,410 | 3,460 | 3,400 | 3,455 | +45 | +1.3% | 309,400 |
2017/02/22 | 3,400 | 3,410 | 3,370 | 3,410 | +5 | +0.1% | 213,700 |
2017/02/21 | 3,400 | 3,440 | 3,380 | 3,405 | +15 | +0.4% | 206,200 |
2017/02/20 | 3,340 | 3,395 | 3,325 | 3,390 | +50 | +1.5% | 245,800 |
2017/02/17 | 3,330 | 3,355 | 3,315 | 3,340 | -5 | -0.1% | 199,600 |
2017/02/16 | 3,340 | 3,380 | 3,330 | 3,345 | +45 | +1.4% | 307,100 |
2017/02/15 | 3,305 | 3,310 | 3,275 | 3,300 | +40 | +1.2% | 207,500 |
2017/02/14 | 3,300 | 3,300 | 3,260 | 3,260 | -40 | -1.2% | 277,900 |
2017/02/13 | 3,310 | 3,325 | 3,280 | 3,300 | ±0 | ±0% | 288,600 |
2017/02/10 | 3,245 | 3,310 | 3,210 | 3,300 | +95 | +3% | 360,100 |
2017/02/09 | 3,190 | 3,210 | 3,155 | 3,205 | -5 | -0.2% | 277,200 |
2017/02/08 | 3,180 | 3,210 | 3,110 | 3,210 | -90 | -2.7% | 618,300 |
2017/02/07 | 3,255 | 3,310 | 3,245 | 3,300 | -15 | -0.5% | 249,600 |
2017/02/06 | 3,310 | 3,315 | 3,285 | 3,315 | +5 | +0.2% | 174,800 |
2017/02/03 | 3,305 | 3,325 | 3,280 | 3,310 | +10 | +0.3% | 163,600 |
2017/02/02 | 3,300 | 3,315 | 3,265 | 3,300 | +25 | +0.8% | 271,600 |
2017/02/01 | 3,245 | 3,285 | 3,215 | 3,275 | +5 | +0.2% | 166,000 |
2017/01/31 | 3,265 | 3,290 | 3,255 | 3,270 | -10 | -0.3% | 157,200 |
2017/01/30 | 3,275 | 3,280 | 3,235 | 3,280 | +25 | +0.8% | 127,700 |
2017/01/27 | 3,270 | 3,285 | 3,250 | 3,255 | -5 | -0.2% | 115,900 |
2017/01/26 | 3,255 | 3,270 | 3,230 | 3,260 | +45 | +1.4% | 173,200 |
2017/01/25 | 3,255 | 3,255 | 3,205 | 3,215 | -35 | -1.1% | 154,000 |
2017/01/24 | 3,220 | 3,260 | 3,220 | 3,250 | ±0 | ±0% | 213,100 |
2017/01/23 | 3,240 | 3,275 | 3,220 | 3,250 | -55 | -1.7% | 134,300 |
2017/01/20 | 3,260 | 3,325 | 3,245 | 3,305 | +40 | +1.2% | 205,400 |
2017/01/19 | 3,280 | 3,285 | 3,240 | 3,265 | +5 | +0.2% | 178,600 |
2017/01/18 | 3,275 | 3,290 | 3,235 | 3,260 | -15 | -0.5% | 186,200 |
2001~
2050
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ツムラ | 334,800円 | +3.8% | -19.9% | 4.06% | 10.95倍 | 0.83倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
久光薬 | 414,200円 | +5.8% | +1.2% | 2.90% | 13.73倍 | 1.10倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
日本新薬 | 356,200円 | +8.0% | -15.3% | 3.48% | 10.00倍 | 0.97倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
サンバイオ | 336,500円 | - | - | 0.00% | - | 155.86倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム